Go Pro

Xylem (XYL) Stock Forecast & Price Target

Xylem logo
$102.51 -6.13 (-5.64%)
Closing price 03:59 PM Eastern
Extended Trading
$103.01 +0.50 (+0.49%)
As of 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Xylem - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
7
Buy
9

Based on 16 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 16 analysts, 7 have given a hold rating, and 9 have given a buy rating for XYL.

Consensus Price Target

$155.00
51.20% Upside
According to the 16 analysts' twelve-month price targets for Xylem, the average price target is $155.00. The highest price target for XYL is $170.00, while the lowest price target for XYL is $130.00. The average price target represents a forecasted upside of 51.20% from the current price of $102.51.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XYL Analyst Ratings Over Time

TypeCurrent Forecast
9/24/25 to 9/24/26
1 Month Ago
8/25/25 to 8/25/26
3 Months Ago
6/26/25 to 6/26/26
1 Year Ago
9/24/24 to 9/24/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
9 Buy rating(s)
9 Buy rating(s)
8 Buy rating(s)
7 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$155.00$155.00$153.54$152.33
Forecasted Upside51.20% Upside37.46% Upside31.68% Upside7.65% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xylem Stock vs. The Competition

TypeXylemIndustrials CompaniesBroader Market
Consensus Rating Score
2.56
2.30
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside51.20% Upside104.48% Upside19.67% Upside
News Sentiment Rating
Positive News

See Recent XYL News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/15/2026
Wolfe Research logo
Wolfe Research
4 of 5 stars
Nigel Coe
Nigel Coe
Not Rated
Initiated CoveragePeer Perform
8/24/2026Boost TargetBuy$145.00 ➝ $150.00+31.92%
8/13/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Joshua Spector
4 of 5 stars
Boost TargetNeutral$135.00 ➝ $138.00+13.18%
8/5/2026 Reiterated RatingHold (C)
7/29/2026Boost TargetNeutral$124.00 ➝ $130.00+5.28%
7/29/2026Boost TargetBuy$157.00 ➝ $160.00+29.57%
7/29/2026Reiterated RatingBuy
7/29/2026Boost TargetOverweight$154.00 ➝ $159.00+27.33%
7/29/2026Boost TargetOutperform$159.00 ➝ $164.00+33.66%
7/29/2026Boost TargetOutperform$163.00 ➝ $165.00+32.13%
6/25/2026 UpgradeHold
4/29/2026Lower TargetOutperform$160.00 ➝ $158.00+35.91%
4/16/2026Lower TargetOverweight$170.00 ➝ $160.00+27.80%
2/23/2026Reiterated RatingHold
2/11/2026 Set Target$158.00+24.59%
1/26/2026Initiated CoverageOutperform
11/18/2025 DowngradeStrong-Buy ➝ Hold
10/29/2025 Set Target$170.00+10.94%
5/15/2025UpgradeHold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:33 PM ET.


Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, September 23, 2026. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Xylem Inc.:

  • The stock is currently trading at $108.61, which is near its 52-week low of $105.29, potentially offering a value entry point for investors given that the consensus price target from analysts is significantly higher at $155.00.
  • Xylem Inc. recently reported Q2 2026 earnings of $1.46 per share, which beat the consensus estimate of $1.34 by $0.12, demonstrating strong profitability with a net margin of 11.15% and a return on equity of 11.77%.
  • Institutional investors continue to show confidence in the company, with State Street Corp increasing its stake by 2.4% in the second quarter and Bank of America Corp DE acquiring a new position of 1,841,734 shares during the same period.
  • The company offers a dividend yield of 1.59% with a payout ratio of 40.95%, providing a steady income stream for investors while maintaining a conservative approach to distributing earnings.
  • Xylem Inc. has a balanced financial profile with a debt-to-equity ratio of 0.23 and a current ratio of 1.61, indicating a strong ability to meet short-term obligations and a manageable level of leverage.

Xylem
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Xylem Inc. for these reasons:

  • The stock has underperformed the industrial sector over the past year, with the current price of $108.61 being significantly below the 50-day moving average of $114.75 and the 200-day moving average of $116.19, suggesting a downward trend.
  • Short interest in Xylem Inc. has increased, with 8,031,075 shares shorted as of August 31, 2026, representing 3.45% of the float, which indicates that some investors are betting against the stock's future performance.
  • The company's revenue growth has been modest, with Q2 2026 revenue of $2.34 billion only slightly exceeding the consensus estimate of $2.34 billion and growing by just 1.5% year-over-year, which may limit upside potential.
  • Some institutional investors have reduced their positions, such as Sequoia Financial Advisors LLC cutting its stake by 22.3% and Corient Private Wealth LP reducing its position by 72.1% in the second quarter, which could signal a lack of confidence in the company's near-term prospects.
  • The stock's beta of 1.00 suggests it moves in line with the overall market, but its recent price action near 52-week lows and the presence of unusual options trading activity, such as a 579% increase in call options volume, may indicate heightened volatility and uncertainty.

XYL Forecast - Frequently Asked Questions

According to the research reports of 16 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $155.00, with a high forecast of $170.00 and a low forecast of $130.00.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 7 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" XYL shares.

According to analysts, Xylem's stock has a predicted upside of 51.20% based on their 12-month stock forecasts.

Xylem has been rated by research analysts at Barclays, Citigroup, Jefferies Financial Group, Mizuho, Robert W. Baird, Royal Bank Of Canada, Stifel Nicolaus, UBS Group, Weiss Ratings, and Wolfe Research in the past 90 days.

Analysts like Xylem more than other "industrials" companies. The consensus rating for Xylem is Moderate Buy while the average consensus rating for "industrials" companies is Hold. Learn more on how XYL compares to other companies.


MarketBeat monitors more than a dozen sources for Xylem analyst ratings, with the most recent rating issued on 9/15/2026.
From Our Partners